Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03344172
Title Pre-Operative Trial (PGHA vs. PGH) for Resectable Pancreatic Cancer (17-134)
Recruitment Terminated
Gender female
Phase Phase II
Variant Requirements No
Sponsors Nathan Bahary, MD
Indications

pancreatic adenocarcinoma

Therapies

Avelumab + Gemcitabine + Hydroxychloroquine + Nab-paclitaxel

Gemcitabine + Hydroxychloroquine + Nab-paclitaxel

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.